S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
NASDAQ:XOMA

XOMA Stock Forecast, Price & News

$39.93
-0.05 (-0.13 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$39.37
Now: $39.93
$41.92
50-Day Range
$32.05
MA: $39.81
$45.61
52-Week Range
$14.14
Now: $39.93
$46.32
Volume21,020 shs
Average Volume25,880 shs
Market Capitalization$440.11 million
P/E RatioN/A
Dividend YieldN/A
Beta1.26
XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and the Asia Pacific. The company has a pipeline of monoclonal antibodies and technologies to license to pharmaceutical and biotechnology companies to further their clinical development. Its proprietary product candidates include X213, an allosteric inhibitor of prolactin action; XMetA, an insulin receptor-activating antibody to provide long-acting reduction of hyperglycemia in Type 2 diabetic patients; IL-2, a therapy for metastatic melanoma and renal cell carcinoma; and PTH1R program, an anti-parathyroid receptor pipeline to address unmet medical needs, including primary hyperparathyroidism and humoral hypercalcemia of malignancy. The company also licenses antibody discovery, optimization, and development technologies. It has research and development collaboration agreements with Novartis Vaccines and Diagnostics, Inc.; Novartis Pharma AG; Novartis International Pharmaceutical Ltd.; Rezolute, Inc.; and Takeda Pharmaceutical Company Limited. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA logo

MarketRank

Overall MarketRank

1.43 out of 5 stars

Analyst Opinion: 1.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
Current SymbolNASDAQ:XOMA
CUSIP98419J10
Phone510-204-7200
Employees11

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.37 million
Book Value$5.03 per share

Profitability

Net Income$-1,980,000.00
Net Margins-102.23%

Miscellaneous

Market Cap$440.11 million
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable
$39.93
-0.05 (-0.13 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XOMA News and Ratings via Email

Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











XOMA (NASDAQ:XOMA) Frequently Asked Questions

How has XOMA's stock price been impacted by Coronavirus?

XOMA's stock was trading at $19.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, XOMA shares have increased by 104.8% and is now trading at $39.93.
View which stocks have been most impacted by COVID-19
.

Is XOMA a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for XOMA in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XOMA stock.
View analyst ratings for XOMA
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than XOMA?

Wall Street analysts have given XOMA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but XOMA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is XOMA's next earnings date?

XOMA is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for XOMA
.

How were XOMA's earnings last quarter?

XOMA Co. (NASDAQ:XOMA) issued its earnings results on Thursday, November, 5th. The biotechnology company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.21) by $0.11. The biotechnology company earned $0.56 million during the quarter, compared to analyst estimates of $2.30 million. XOMA had a negative net margin of 102.23% and a negative return on equity of 28.83%.
View XOMA's earnings history
.

What price target have analysts set for XOMA?

2 equities research analysts have issued 12 month target prices for XOMA's shares. Their forecasts range from $30.00 to $36.00. On average, they anticipate XOMA's share price to reach $33.00 in the next twelve months. This suggests that the stock has a possible downside of 17.4%.
View analysts' price targets for XOMA
or view Wall Street analyst' top-rated stocks.

Are investors shorting XOMA?

XOMA saw a drop in short interest in December. As of December 31st, there was short interest totaling 441,800 shares, a drop of 20.9% from the December 15th total of 558,800 shares. Based on an average daily volume of 40,300 shares, the short-interest ratio is currently 11.0 days.
View XOMA's Short Interest
.

Who are some of XOMA's key competitors?

What other stocks do shareholders of XOMA own?

Who are XOMA's key executives?

XOMA's management team includes the following people:
  • Mr. James R. Neal, CEO & Director (Age 64, Pay $798.65k)
  • Mr. Thomas M. Burns, Sr. VP of Fin. & CFO (Age 46, Pay $552.2k)
  • Mr. Danny J. Hart Jr., VP & Gen. Counsel (Age 44)

What is XOMA's stock symbol?

XOMA trades on the NASDAQ under the ticker symbol "XOMA."

How do I buy shares of XOMA?

Shares of XOMA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is XOMA's stock price today?

One share of XOMA stock can currently be purchased for approximately $39.93.

How big of a company is XOMA?

XOMA has a market capitalization of $440.11 million and generates $18.37 million in revenue each year. The biotechnology company earns $-1,980,000.00 in net income (profit) each year or ($0.23) on an earnings per share basis. XOMA employs 11 workers across the globe.

What is XOMA's official website?

The official website for XOMA is www.xoma.com.

How can I contact XOMA?

XOMA's mailing address is 2200 POWELL STREET SUITE 310, EMERYVILLE CA, 94608. The biotechnology company can be reached via phone at 510-204-7200 or via email at [email protected]

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.